Jain Rita

Jain Rita is listed in filings as Director at Avalo Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 4, 2026, including 15 public disclosures. Recent filings connect the profile to Avalo Therapeutics, Inc. (AVTX), AnaptysBio, Inc. (ANAB), SAB Biotherapeutics, Inc. (SABS), and Celldex Therapeutics, Inc. (CLDX). The current snapshot covers public activity from Jun 17, 2024 to Jun 4, 2026. Reported amounts are shown as $280.6K to $241.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.